The ever increasing role of percutaneous interventions in coronary revascularisation

Hellenic Journal of Cardiology

Volumn 51, Issue 6, 2010, Pages 512-517

  Spanos, Vassilis N ^a   Toutouzas, Pavlos K ^a  

^a Athens Euroclinic   (Greece)

Author keywords

Coronary artery bypass; Drug eluting stents; Left main; Multivessel disease

Indexed keywords

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOLOGY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL REVASCULARIZATION; STENTS;

EID: 78650605347     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Gruentzig AR. Percutaneous transluminal coronary angioplasty. Semin Roentgenol. 1981; 16: 152-153.
2. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001; 103: 192-195.
3. Di Mario C, Gil R, Camenzind E, et al. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol. 1995; 75: 772-777.
4. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol. 1992; 19: 926-935.
5. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316: 701-706.
6. Nordrehaug JE, Priestly KA, Chronos NA, Rickards AF, Buller NP, Sigwart U. Self-expanding stents for emergency treatment of acute vessel closure following coronary angioplasty: immediate and long-term results. J Interv Cardiol. 1994; 7: 161-164.
7. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994; 331: 496-501.
8. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994; 331: 489-495.
9. Sigwart U. Anticoagulation after intracoronary stent insertion. Br Heart J. 1995; 73: 393.
10. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol. 1994; 24: 996-1003.
11. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation. 1996; 94: 1519-1527.
12. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 91: 1676-1688.
13. Maier W, Windecker S, Boersma E, Meier B. Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996. Eur Heart J. 2001; 22: 1733-1740.
14. Kastrati A, Schömig A, Elezi S, et al. Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation. 1999; 100: 1285-1290.
15. Odell A, Grip L, Hallberg LR-M. Restenosis after percutaneous coronary intervention (PCI): experiences from the patients' perspective. Eur J Cardiovasc Nurs. 2006; 5: 150-157.
16. Takagi T, Stankovic G, Finci L, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002; 106: 698-702.
17. Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46: 575-581.
18. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008; 118: 381-388.
19. Spanos V, Stankovic G, Tobis J, Colombo A. The challenge of in-stent restenosis: insights from intravascular ultrasound. Eur Heart J. 2003; 24: 138-150.
20. Colombo A, Chieffo A. Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007; 116: 1424-1432.
21. Serruys PW, Ong ATL, Morice M-C, et al. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention. 2005; 1: 147-156.
22. Ong ATL, McFadden EP, Regar E, de Jaegere PPT, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005; 45: 2088-2092.
23. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007; 356: 998-1008.
24. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356: 1030-1039.
25. Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007; 357: 1393-1402.
26. Mauri L, Silbaugh TS, Wolf RE, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 2008; 118: 1817-1827.
27. Stone GW, Lansky AJ, Pocock SJ, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009; 360: 1946-1959.
28. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006; 151: 1260-1264.
29. Stone GW, Ellis SG, Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation. 2007; 115: 2842-2847.
30. Spanos V, Karabinos E, Arapogianni A, Toutouzas P. Efficacy and safety of multiple drug-eluting stent implantation on everyday clinical practice. A single center series with midterm clinical follow-up. Angiology 2007.
31. Sianos G, Morel M-A, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005; 1: 219-227.
32. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-972.
33. Morice MC. Contemporary indications for left main stenting: new insights from SYNTAX Trial. Transcatheter Cardiovascular Therapeutics 2009 [Internet]. Available from: http://www.tctmd.com/txshow.aspx?tid=938648&id= 81242&trid=938634.
34. Teirstein PS. Percutaneous revascularization is the preferred strategy for patients with significant left main coronary stenosis. Circulation. 2009; 119: 1021-1033.
35. Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation. 2009; 119: 680-686.